Evidence map›Paper›PMID 41667711›Full record

ArticleNature biotechnology2026

Identifying 3D signal overlaps in spatial transcriptomics data with ovrlpy.

Sebastian Tiesmeyer, Niklas Müller-Bötticher, Alexander Malt, Leyao Ma, Sergio Marco-Salas, Paul Kiessling, Paul Horn, Adrien Guillot, Louis B Kuemmerle, Frank Tacke and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Spatial Multiomics Reveal Insights Into ADC Efficacy.European journal of immunology · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sebastian Tiesmeyer *Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Center of Digital Health, Berlin, Germany.
Niklas Müller-Bötticher *Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Center of Digital Health, Berlin, Germany.
Alexander MaltBerlin Institute of Health at Charité-Universitätsmedizin Berlin, Center of Digital Health, Berlin, Germany.
Leyao MaFreie Universität Berlin, Department of Mathematics and Computer Science, Berlin, Germany.
Sergio Marco-SalasScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-4636-0322
Paul KiesslingDepartment of Nephrology, Rheumatology, and Clinical Immunology, University Hospital RWTH Aachen, Aachen, Germany.ORCID http://orcid.org/0000-0002-9794-9532
Paul HornDepartment of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany.ORCID http://orcid.org/0000-0002-8755-7703
Adrien GuillotDepartment of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany.ORCID http://orcid.org/0000-0002-6002-9986
Louis B KuemmerleInstitute of Computational Biology, Computational Health Center, Helmholtz Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-9193-1243
Frank TackeDepartment of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany.ORCID http://orcid.org/0000-0001-6206-0226
Fabian J TheisInstitute of Computational Biology, Computational Health Center, Helmholtz Munich, Munich, Germany.
Christoph KuppeDepartment of Nephrology, Rheumatology, and Clinical Immunology, University Hospital RWTH Aachen, Aachen, Germany.ORCID http://orcid.org/0000-0003-4597-9833
Mats NilssonScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-9985-0387
Roland EilsBerlin Institute of Health at Charité-Universitätsmedizin Berlin, Center of Digital Health, Berlin, Germany.ORCID http://orcid.org/0000-0002-0034-4036
Brian LongAllen Institute for Brain Science, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-7793-5969
Naveed IshaqueBerlin Institute of Health at Charité-Universitätsmedizin Berlin, Center of Digital Health, Berlin, Germany. naveed.ishaque@bih-charite.de.ORCID http://orcid.org/0000-0002-8426-901X

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01KD2443Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 031L0265Deutsche Forschungsgemeinschaft (German Research Foundation) 35081457
6 · The paper itself

Abstract

Imaging-based spatially resolved transcriptomics can localize transcripts within tissue sections in three dimensions. However, cell segmentation, which assigns transcripts to cells, is usually performed in two dimensions and spatial doublets in the vertical dimension result in segmented cells containing transcripts originating from multiple cell types. Here we present a computational tool called ovrlpy that identifies overlapping cells, tissue folds and inaccurate cell segmentation by analyzing transcript localization in three dimensions.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.